The New England journal of medicine
-
Randomized Controlled Trial Multicenter Study Clinical Trial
A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease.
Restenosis after coronary stenting necessitates repeated percutaneous or surgical revascularization procedures. The delivery of paclitaxel to the site of vascular injury may reduce the incidence of neointimal hyperplasia and restenosis. ⋯ As compared with bare-metal stents, the slow-release, polymer-based, paclitaxel-eluting stent is safe and markedly reduces the rates of clinical and angiographic restenosis at nine months.
-
Randomized Controlled Trial Multicenter Study Comparative Study Clinical Trial
A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation.
Vasopressin is an alternative to epinephrine for vasopressor therapy during cardiopulmonary resuscitation, but clinical experience with this treatment has been limited. ⋯ The effects of vasopressin were similar to those of epinephrine in the management of ventricular fibrillation and pulseless electrical activity, but vasopressin was superior to epinephrine in patients with asystole. Vasopressin followed by epinephrine may be more effective than epinephrine alone in the treatment of refractory cardiac arrest.